By Bahk Eun-ji
Hyundai Pharm has received approval from the U.S. Food and Drug Administration (FDA) for a phase 2 clinical trial of its new drug treating type 2 diabetes, the company said Sunday.
The drug, HDNO-1605 (HD-6277), targets the G-protein-coupled receptor 40 (GPR40), also known as free fatty acid receptor 1, which plays a pivotal role in the regulation of insulin secretion, according to the firm.
It is proven to lessen hypoglycemia and other side-effects of diabetes medications, according to Hyundai, which says diabetic patients can effectively regulate their insulin levels by taking only one pill a day.
The company has been developing HDNO-1605 (HD-6277), which is taken orally, as a state-sponsored project funded by the Ministry of Health and Welfare. The drug has already completed a phase 1 clinical trial in Europe.
Hyundai Pharm has received approval from the U.S. Food and Drug Administration (FDA) for a phase 2 clinical trial of its new drug treating type 2 diabetes, the company said Sunday.
The drug, HDNO-1605 (HD-6277), targets the G-protein-coupled receptor 40 (GPR40), also known as free fatty acid receptor 1, which plays a pivotal role in the regulation of insulin secretion, according to the firm.
It is proven to lessen hypoglycemia and other side-effects of diabetes medications, according to Hyundai, which says diabetic patients can effectively regulate their insulin levels by taking only one pill a day.
The company has been developing HDNO-1605 (HD-6277), which is taken orally, as a state-sponsored project funded by the Ministry of Health and Welfare. The drug has already completed a phase 1 clinical trial in Europe.
![[PHOTOS] Harvest season arrives](https://img.koreatimes.co.kr/upload/newsV2/images/harvesr_0002_0e73d9d71cde7.JPG/dims/resize/178/optimize)
![[EXCLUSIVE] Lawmakers to submit resolution urging China to free N. Korean escapees](https://img.koreatimes.co.kr/upload/thumbnailV2/c26dcfe337d74c319d1b2ae87f08fcd5.jpg/dims/resize/178/optimize)
![[INTERVIEW] ONEUS returns as 'mermaid prince'](https://img.koreatimes.co.kr/upload/thumbnailV2/8cc3b8d992cd4b8bb43395b014670ca2.jpg/dims/resize/178/optimize)
![[INTERVIEW] Yim Si-wan went extra mile to portray legendary athlete in 'Road to Boston'](https://img.koreatimes.co.kr/upload/thumbnailV2/fdd49ca391cf4ce785bd7136efd0bfa2.jpg/dims/resize/178/optimize)
